The global dental bone graft substitutes market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Increasing demand from customers for dental bone graft substitutes, growing inclination towards cosmetic dentistry, and rising industry standards are spurring the growth of the dental bone grafts substitutes market. However, unfavorable reimbursement scenarios in some countries is hampering the growth of the dental bone grafts substitutes market.
The global dental bone graft substitutes market is segmented on the basis of type, application, and region. The geographic analysis covers North America, Europe, Asia-Pacific, and Rest of the World (RoW). RoW includes Latin America, the Middle East, and Africa.
The European region is estimated to account for the largest share of the dental bone graft substitutes market in 2016. As implant dentistry originated in the European region, the penetration rate of dental bone graft substitutes is very high in this region. The main factors driving the growth of the Europe market are the continuous increase in aging population, governmental expenditure on oral healthcare across the region, and the high reimbursement rate although limited to Germany, Sweden, and the Netherlands.
The dental bone graft substitutes market is a competitive market with a large number of companies operational in the market. The competitive landscape includes an in-depth market share analysis along with the key business strengths of the leading market players. Some of the leading players offering dental bone graft substitutes products are Geistlich Pharma AG (Switzerland), Zimmer Dental Inc. (U.S.), Dentsply Sirona (U.S.), LifeNet Health (U.S.), RTI Surgical, Inc. (U.S.), BioHorizons IPH, Inc. (U.S.), and ACE Surgical Supply Company, Inc. (U.S.).
Comments
Post a Comment